Hi,
I have a couple of thoughts on the method of dosing that Dr. E. is using for Cindy. Remember, she had been taking GcMAF at a relatively low dose, 25 ng, for over a year before Dr. Enlander started increasing her dose. Also, she has not been sick for many years. I am not sure how these two things may play together, but possibly, having taken GcMAF for so long before raising the dose, enough pathogens have been "pacmanned" so that she is not getting as much of an inflammatory response as she might have, had she raised the dose in the beginning months of treatment.
Her story is very intriguing to me because, though I have been sick a long time, I have also been taking GcMAF at first 50 ngs then 25 ngs for a bit over a year. I started with 50 ngs, briefly tried raising the dose (under medical supervision) and I definitely could not handle more at that time. Even at 50 ngs, I had to take a break of 3 months due to inflammation, after 6 months. Then I was restarted at 25 ngs and have had no side-effects at that dose.
Maybe now, after all these months on GcMAF, I too would be able to slowly raise my dose without side-effects. My immune tests have mostly normalized in the past year, I do have measurable inflammation but not at a very high level. I'd guess that my overall symptoms have improved about 30% in a year. I am also taking GcMAF from the same source as Cindy.
I will be asking my doctor about this soon, but at the moment I am considering the hypothesis that taking GcMAF at a tolerable level for long enough, might prepare the ground for being able to tolerate a higher dose. Cindy's experience is certainly heartening.
Protocols for GcMAF are certainly experimental at this stage and it is hard to predict who will respond and who won't--yet the experience of some of the doctors giving it, indicates that certain co-infections make it harder to tolerate and need to be treated first.
My vitamin D receptors would have theoretically predicted that I would be a low or slow responder. My nagalase has slowly gone down while taking GcMAF. High nagalase is another test that some doctors are using as one criterion for prescribing GcMAF, although I don't think Dr. Enlander is.
As another note: I did have considerable cognitive problems which have slowly improved but are not healed. I also had problems with the HPA axis which seem much more normal now. I also have clinical indications that my blood volume has increased.
Best wishes,
Sushi